OCT 22, 2020 8:31 AM PDT

Using Liposomes to Deliver Repair Packages to the Heart

WRITTEN BY: Jasper Cantrell

The secret to any successful drug is not just its ability to treat a disease but its ability to target the disease exclusively. In cardiology, scientists are trying to design a drug that heals patients’ hearts after a heart attack.

During a heart attack, there is restricted blood flow to areas of the heart. This causes cells in that area to die, resulting in tissue death. The body’s repair system can actually be detrimental in this case, as the immune system causes inflammation at the site of tissue death. This is to remove dead cells to make way for tissue repair, but what results is often a scar rather than the area’s true repair.

Azithromycin has been a promising drug candidate for assisting the body in repairing myocardial infarcts (the area of tissue death in the heart). It shifts the early immune system response from inducing inflammation to inducing repair. Unfortunately, azithromycin suffers from off-target toxicity and therefore struggles to produce safe results.

A new study out of the University of Kentucky hoped to alleviate the toxicity issue by using liposomes to transport azithromycin to the damaged heart tissue. Liposomes are small spherical packages created by lipids. They can protect the contents of the package until they are delivered to a target. Using this method of delivery, the team hoped to apply azithromycin to the damaged heart tissue with as little toxic side effects as possible.

The team first assessed whether the azithromycin loaded liposomes would accumulate in mouse hearts that had suffered from a heart attack. Both liposomes and azithromycin were confirmed to be taken up by immune cells called macrophages and transported to the site of tissue death with no adverse effects. By comparison, free azithromycin reduced heart rate and caused several other heart issues when given at the same dose.

The azithromycin loaded liposomes managed to shift the immune response from inflammatory to reparative successfully. This was done by activating reparative immune cells over inflammatory ones while also decreasing inflammatory signals’ expression and increasing anti-inflammatory signaling. Finally, the mouse hearts given azithromycin loaded liposomes recovered faster had increased heart strength after the repair and had reduced scarring.

This study showed that liposomes could be used to deliver azithromycin to sites of damage in the heart after a heart attack without inducing toxicity. The resulting reduction of not only scarring but in mortality makes this method very attractive for future treatments.

The study concludes, “Our findings strongly support clinical trials using L-AZM as a novel and clinically relevant therapy to improve cardiac recovery and reduce heart failure post-MI in humans.”

Sources: Nature Scientific Reports, Cipla

About the Author
  • Hey everyone! My name is Jasper and, considering I am pretty new here to Labroots, I figured I would introduce myself. I received my bachelor’s from the University of California at Riverside back in 2016. I started off my career a few years ago with a job at a University over in New York, before moving over into the industry. I'm happy to be writing content for Labroots, and I hope you enjoy it!
You May Also Like
OCT 06, 2020
Cardiology
A New Heart Drug Taken from a Yellow Dye
OCT 06, 2020
A New Heart Drug Taken from a Yellow Dye
Cardiovascular disease is an ever-present issue in the modern world.  One of the most unfortunate cardiovascular ev ...
OCT 21, 2020
Cell & Molecular Biology
Extracellular Vesicles Help Heart Cells Survive a Heart Attack
OCT 21, 2020
Extracellular Vesicles Help Heart Cells Survive a Heart Attack
During a heart attack, blood flow is blocked and cells lose oxygen and begin to die. Scientists are developing many new ...
JAN 05, 2021
Cell & Molecular Biology
Brown Fat Appears to Protect Against Disease
JAN 05, 2021
Brown Fat Appears to Protect Against Disease
Not all fat is the same. White fat is what we're usually thinking of when we think of flabby tissue that stores excess c ...
MAR 09, 2021
Cardiology
A Lifestyle Change Could Reduce a Diabetic's Cardiovascular Risk
MAR 09, 2021
A Lifestyle Change Could Reduce a Diabetic's Cardiovascular Risk
Nowadays, everyone thinks there is a pill or gummy that will fix everything. That may be true for the occasional headach ...
APR 08, 2021
Immunology
It's Not Just Cholesterol That Clogs Arteries
APR 08, 2021
It's Not Just Cholesterol That Clogs Arteries
Researchers have discovered a gene that is directly linked to the development of cardiovascular diseases, such as high b ...
APR 20, 2021
Cardiology
How Low Can You Go? Diastolic Blood Pressure Standards May Change
APR 20, 2021
How Low Can You Go? Diastolic Blood Pressure Standards May Change
Blood pressure readings are a standard part of even the most basic health checks. Now some researchers are suggesting th ...
Loading Comments...